Complex Disease Dynamics and the Design of Influenza Vaccination Programs

article has not abstract

Vyšlo v časopise: Complex Disease Dynamics and the Design of Influenza Vaccination Programs. PLoS Med 10(11): e32767. doi:10.1371/journal.pmed.1001553
Kategorie: Perspective
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001553

Souhrn

article has not abstract

Zdroje

1. CarratF, FlahaultA (2007) Influenza vaccine: the challenge of antigenic drift. Vaccine 25 : 6852–6862 doi:10.1016/j.vaccine.2007.07.027

2. SongJY, CheongHJ, HwangIS, ChoiWS, JoYM, et al. (2010) Long-term immunogenicity of influenza vaccine among the elderly: Risk factors for poor immune response and persistence. Vaccine 28 : 3929–3935 doi:10.1016/j.vaccine.2010.03.067

3. YuH, AlonsoWJ, FengL, TanY, ShuY, et al. (2013) Characterization of regional influenza seasonality patterns in China and implications for vaccination strategies: spatio-temporal modelling of surveillance data. PLoS Med 10(11): e1001552 doi:10.1371/journal.pmed.1001552

4. Influenza Division, National Center for Immunization and Respiratory Diseases, CDC (2013) Prevention and control of seasonal influenza with vaccines. MMWR Recommendations and reports: morbidity and mortality weekly report Recommendations and reports/Centers for Disease Control 62 : 1–43.

5. ViboudC, AlonsoWJ, SimonsenL (2006) Influenza in tropical regions. PLoS Med 3(4): e89 doi:10.1371/journal.pmed.0030089

6. NgTP, PweeKH, NitiM, GohLG (2002) Influenza in Singapore: assessing the burden of illness in the community. Ann Acad Med Singapore 31 : 182–188.

7. CowlingBJ, WongIOL, HoL-M, RileyS, LeungGM (2006) Methods for monitoring influenza surveillance data. Int J Epidemiol 35 : 1314–1321 doi:10.1093/ije/dyl162

8. AlonsoWJ, ViboudC, SimonsenL, HiranoEW, DaufenbachLZ, et al. (2007) Seasonality of influenza in Brazil: a traveling wave from the Amazon to the subtropics. Am J Epidemiol 165 : 1434–1442 doi:10.1093/aje/kwm012

9. CollinN, de RadiguèsX (2009) World Health Organization H1N1 Vaccine Task Force (2009) Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza. Vaccine 27 : 5184–5186 doi:10.1016/j.vaccine.2009.06.034

10. Szymczakiewicz-MultanowskaA, GrothN, BugariniR, LattanziM, CasulaD, et al. (2009) Safety and immunogenicity of a novel influenza subunit vaccine produced in mammalian cell culture. J Infect Dis 200(11): 1801–2 doi:10.1086/605505

11. LiS, LiuC, KlimovA, SubbaraoK, PerdueML, et al. (1999) Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses. J Infect Dis 179 : 1132–1138 doi:10.1086/314713

12. D'AoustMA, CoutureMMJ, CharlandN, TrépanierS, LandryN, et al. (2010) The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza. Plant Biotechnol J 8(5): 607–19 doi: 10.1111/j.1467-7652.2009.00496.x